{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:49:55Z","timestamp":1788544195241,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["FGFG-2022-0001"],"award-info":[{"award-number":["FGFG-2022-0001"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.tiv.2024.105940","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T16:38:20Z","timestamp":1726072700000},"page":"105940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["In vitro modelling of Parkinson's disease using 6-OHDA is associated with increased NQO2 activity"],"prefix":"10.1016","volume":"101","author":[{"given":"Ekaterina R.","family":"Verbovaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya A.","family":"Kadnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya O.","family":"Logvinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana A.","family":"Antipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail V.","family":"Voronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei B.","family":"Seredenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2024.105940_bb0005","series-title":"Genotoxicity and DNA Repair: A Practical Approach","first-page":"199","article-title":"The comet assay: High throughput use of FPG","author":"Azqueta","year":"2014"},{"key":"10.1016\/j.tiv.2024.105940_bb0010","first-page":"953","article-title":"Osthole attenuated cytotoxicity induced by 6-OHDA in SH-SY5Y cells through inhibition of JAK\/STAT and MAPK pathways","volume":"26","author":"Barangi","year":"2023","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.tiv.2024.105940_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.tiv.2024.105940_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41419-021-03441-0","article-title":"Expanding the role of proteasome homeostasis in Parkinson\u2019s disease: beyond protein breakdown","volume":"12","author":"Bi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tiv.2024.105940_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03033271","article-title":"The role of adrenochrome in stimulating the oxidation of catecholamines","volume":"1","author":"Bindoli","year":"1999","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.tiv.2024.105940_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102136","article-title":"Calcium channels and iron metabolism: a redox catastrophe in Parkinson\u2019s disease and an innovative path to novel therapies?","volume":"47","author":"Boag","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.tiv.2024.105940_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acs.chemrestox.6b00256","article-title":"Formation and biological targets of Quinones: cytotoxic versus Cytoprotective effects","volume":"30","author":"Bolton","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2024.105940_bb0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/tx9902082","article-title":"Role of quinones in toxicology","volume":"13","author":"Bolton","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2024.105940_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/jpet.118.253260","article-title":"Is there sufficient evidence that the melatonin binding site MT3 is Quinone reductase 2?","volume":"368","author":"Boutin","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2024.105940_bb0050","doi-asserted-by":"crossref","first-page":"11417","DOI":"10.1021\/bi049162o","article-title":"Crystal structure of quinone reductase 2 in complex with resveratrol","volume":"43","author":"Buryanovskyy","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.tiv.2024.105940_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314835","article-title":"The neuroprotective potentiality of flavonoids on Alzheimer\u2019s disease","volume":"23","author":"Calderaro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2024.105940_bb0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.freeradbiomed.2015.07.150","article-title":"In cellulo monitoring of quinone reductase activity and reactive oxygen species production during the redox cycling of 1,2 and 1,4 quinones","volume":"89","author":"Cassagnes","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2024.105940_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.freeradbiomed.2018.03.002","article-title":"Oxidative stress and neurodegeneration: the possible contribution of quinone reductase 2","volume":"120","author":"Cassagnes","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2024.105940_bb0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","article-title":"Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice","volume":"28","author":"Chen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tiv.2024.105940_bb0075","article-title":"Protective effects of Jujubosides on 6-OHDA-induced neurotoxicity in SH-SY5Y and SK-N-SH cells","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.tiv.2024.105940_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.660641","article-title":"Association of NQO2 with UDP-glucuronosyltransferases reduces menadione toxicity in neuroblastoma cells","volume":"12","author":"Chhour","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tiv.2024.105940_bb0085","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3233\/JAD-190863","article-title":"Molecular mechanisms and genetics of oxidative stress in Alzheimer\u2019s disease","volume":"72","author":"Cioffi","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tiv.2024.105940_bb0090","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1042\/BST0351156","article-title":"Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications","volume":"35","author":"de la Lastra","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.tiv.2024.105940_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cbi.2010.09.010","article-title":"Induction of the Keap1\/Nrf2\/ARE pathway by oxidizable diphenols","volume":"192","author":"Dinkova-Kostova","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2024.105940_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.2010.05906.x","article-title":"VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse","volume":"1216","author":"Eiden","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tiv.2024.105940_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/jbcpp-2019-0270","article-title":"6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels","volume":"32","author":"Elyasi","year":"2020","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.tiv.2024.105940_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109184","article-title":"Protective effects of DA-9805 on dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity in the models of Parkinson\u2019s disease","volume":"117","author":"Eo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tiv.2024.105940_bb0115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/mds.10486","article-title":"Nigral glutathione deficiency is not specific for idiopathic Parkinson\u2019s disease","volume":"18","author":"Fitzmaurice","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tiv.2024.105940_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/mutage\/11.2.169","article-title":"Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay","volume":"11","author":"Fortini","year":"1996","journal-title":"Mutagenesis"},{"key":"10.1016\/j.tiv.2024.105940_bb0125","doi-asserted-by":"crossref","first-page":"23829","DOI":"10.1074\/jbc.M801371200","article-title":"Quinone reductase 2 is a catechol quinone reductase","volume":"283","author":"Fu","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2024.105940_bb0130","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7","article-title":"Converging pathways in neurodegeneration, from genetics to mechanisms","volume":"21","author":"Ga","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tiv.2024.105940_bb0135","series-title":"Handbook of Neurotoxicity","first-page":"639","article-title":"6-Hydroxydopamine as preclinical model of Parkinson\u2019s disease","author":"Galindo","year":"2014"},{"key":"10.1016\/j.tiv.2024.105940_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312827","article-title":"The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2024.105940_bb0145","first-page":"329","article-title":"Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine","volume":"292","author":"Glinka","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tiv.2024.105940_bb0150","first-page":"633","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tiv.2024.105940_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111729","article-title":"Mechanistic insights and perspectives involved in neuroprotective action of quercetin","volume":"140","author":"Grewal","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tiv.2024.105940_bb0160","doi-asserted-by":"crossref","first-page":"18814","DOI":"10.1016\/S0021-9258(17)32239-1","volume":"269","author":"Hatahet","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2024.105940_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0304-3835(01)00695-4","article-title":"Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention","volume":"174","author":"Hayes","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tiv.2024.105940_bb0170","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/acschemneuro.7b00034","article-title":"Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson\u2019s disease?","volume":"8","author":"Herrera","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tiv.2024.105940_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1471-4159.2006.04025.x","article-title":"Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics","volume":"99","author":"Holtz","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tiv.2024.105940_bb0180","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2007.01.043","article-title":"Activation of the unfolded protein response in Parkinson\u2019s disease","volume":"354","author":"Hoozemans","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tiv.2024.105940_bb0185","article-title":"Luteolin modulates 6-hydroxydopamine-induced transcriptional changes of stress response pathways in PC12 cells","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tiv.2024.105940_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bjc.6605100","article-title":"Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours","volume":"101","author":"Hussein","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tiv.2024.105940_bb0195","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.tiv.2024.105940_bb0200","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/molpharm.120.000105","article-title":"Molecular pharmacology of NRH:quinone oxidoreductase 2: a detoxifying enzyme acting as an undercover toxifying enzyme","volume":"98","author":"Janda","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tiv.2024.105940_bb0205","doi-asserted-by":"crossref","first-page":"21624","DOI":"10.1038\/s41598-023-44666-7","article-title":"Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson\u2019s disease","volume":"13","author":"Janda","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2024.105940_bb0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10517-015-2886-9","article-title":"Cytoprotective effect of Afobazole and its Main metabolite M-11","volume":"159","author":"Kadnikov","year":"2015","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.tiv.2024.105940_bb0215","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1134\/S1819712420010110","article-title":"Analysis of Quinone reductase 2 implication in mechanism of antiparkinsonian action of Afobazole","volume":"14","author":"Kadnikov","year":"2020","journal-title":"Neurochem. J."},{"key":"10.1016\/j.tiv.2024.105940_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05342","article-title":"Sesaminol prevents Parkinson's disease by activating the Nrf2-ARE signaling pathway","volume":"6","author":"Kaji","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.tiv.2024.105940_bb0225","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4062\/biomolther.2018.211","article-title":"7,8,4\u2032-trihydroxyisoflavone, a metabolized product of Daidzein, attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells","volume":"27","author":"Ko","year":"2019","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.tiv.2024.105940_bb0230","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1186\/1471-2164-15-1154","article-title":"Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson's disease","volume":"15","author":"Krishna","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tiv.2024.105940_bb0235","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1080\/10715762.2018.1489128","article-title":"Resveratrol provides neuroprotective effects through modulation of mitochondrial dynamics and ERK1\/2 regulated autophagy","volume":"52","author":"Lin","year":"2018","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.tiv.2024.105940_bb0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2005.01.017","article-title":"Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells","volume":"1038","author":"Man\u00e1kov\u00e1","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.tiv.2024.105940_bb0245","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/tx700254q","article-title":"Oxidation chemistry of norepinephrine: partitioning of the O-quinone between competing cyclization and chain breakdown pathways and their roles in melanin formation","volume":"20","author":"Manini","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2024.105940_bb0250","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0332-6","article-title":"Impaired dopamine metabolism in Parkinson\u2019s disease pathogenesis","volume":"14","author":"Masato","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tiv.2024.105940_bb0255","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0891-5849(98)00167-1","article-title":"Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product","volume":"26","author":"Metodiewa","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2024.105940_bb0260","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0041-008X(92)90273-U","article-title":"Quinone chemistry and toxicity","volume":"112","author":"Monks","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2024.105940_bb0265","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1002\/anie.201811122","article-title":"Dopamine, oxidative stress and protein-Quinone modifications in Parkinson\u2019s and other neurodegenerative diseases","volume":"58","author":"Monzani","year":"2019","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.tiv.2024.105940_bb0270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"24","author":"Moon","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.tiv.2024.105940_bb0275","series-title":"Handbook of Neurotoxicity","first-page":"973","article-title":"Regulation of DA homeostasis and role of VMAT2 in DA-induced neurodegeneration","author":"Mosharov","year":"2014"},{"key":"10.1016\/j.tiv.2024.105940_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111865","article-title":"The enzyme-modified comet assay: past, present and future","volume":"147","author":"Muruzabal","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tiv.2024.105940_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112399","article-title":"The emerging role of the lysosome in Parkinson\u2019s disease","volume":"9","author":"Navarro-Romero","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tiv.2024.105940_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9090901","article-title":"Oxidative stress, neuroinflammation and mitochondria in the pathophysiology of amyotrophic lateral sclerosis","volume":"9","author":"Obrador","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.tiv.2024.105940_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2008.04.001","article-title":"Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells","volume":"250","author":"Ossola","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2024.105940_bb0300","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.dib.2018.10.069","article-title":"Data on the effect of angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines","volume":"21","author":"Parga","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.tiv.2024.105940_bb0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1631\/jzus.B2000344","article-title":"DNA alkylation lesion repair: outcomes and implications in cancer chemotherapy","volume":"22","author":"Peng","year":"2021","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.tiv.2024.105940_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.650597","article-title":"Melatonin as a chronobiotic and cytoprotective agent in Parkinson\u2019s disease","volume":"12","author":"P\u00e9rez-Lloret","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tiv.2024.105940_bb0315","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson's disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.tiv.2024.105940_bb0320","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tiv.2007.07.005","article-title":"Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines","volume":"22","author":"Puttonen","year":"2008","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2024.105940_bb0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/rej.2018.2062","article-title":"Phytohormone abscisic acid protects human neuroblastoma SH-SY5Y cells against 6-Hydroxydopamine-induced neurotoxicity through its antioxidant and antiapoptotic properties","volume":"22","author":"Rafiepour","year":"2019","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.tiv.2024.105940_bb0330","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2018.05.002","article-title":"Antioxidant response elements: discovery, classes, regulation and potential applications","volume":"17","author":"Raghunath","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.tiv.2024.105940_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23062914","article-title":"Neuroprotective effect of Luteolin-7-O-glucoside against 6-OHDA-induced damage in undifferentiated and RA-differentiated SH-SY5Y cells","volume":"23","author":"Rehfeldt","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2024.105940_bb0340","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3109\/10715762.2011.605788","article-title":"Insights into the redox cycle of human quinone reductase 2","volume":"45","author":"Reybier","year":"2011","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.tiv.2024.105940_bb0345","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/jnc.12686","article-title":"Protective and toxic roles of dopamine in Parkinson\u2019s disease","volume":"129","author":"Segura-Aguilar","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tiv.2024.105940_bb0350","first-page":"50","article-title":"Afobazole metabolism in rats","volume":"71","author":"Seredenin","year":"2008","journal-title":"Eksp. Klin. Farmakol."},{"key":"10.1016\/j.tiv.2024.105940_bb0355","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2174\/092986709787846578","article-title":"Mitochondrial respiratory complex I: structure, function and implication in human diseases","volume":"16","author":"Sharma","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tiv.2024.105940_bb0360","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.neuint.2013.03.001","article-title":"Neuroprotective effects of aqueous extracts of Uncaria tomentosa: insights from 6-OHDA induced cell damage and transgenic Caenorhabditis elegans model","volume":"62","author":"Shi","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tiv.2024.105940_bb0365","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tiv.2024.105940_bb0370","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.tiv.2024.105940_bb0375","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbadis.2012.07.009","article-title":"The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson\u2019s disease","volume":"1832","author":"Solesio","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2024.105940_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242174","article-title":"Dihydronicotinamide riboside promotes cell-specific cytotoxicity by tipping the balance between metabolic regulation and oxidative stress","volume":"15","author":"Sonavane","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.tiv.2024.105940_bb0385","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.freeradbiomed.2010.05.009","article-title":"Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide","volume":"49","author":"Song","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2024.105940_bb0390","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-60327-418-0_17","article-title":"Measurement of DNA interstrand crosslinking in individual cells using the single cell gel electrophoresis (comet) assay","volume":"613","author":"Spanswick","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tiv.2024.105940_bb0395","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxlet.2003.09.010","article-title":"Sensitivity of the FPG protein towards alkylation damage in the comet assay","volume":"146","author":"Speit","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tiv.2024.105940_bb0400","doi-asserted-by":"crossref","first-page":"15318","DOI":"10.1016\/S0021-9258(17)36608-5","article-title":"Substrate specificity of Fpg protein. Recognition and cleavage of oxidatively damaged DNA","volume":"269","author":"Tchou","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2024.105940_bb0405","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tiv.2005.01.006","article-title":"Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells","volume":"19","author":"Tirmenstein","year":"2005","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2024.105940_bb0410","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1021\/jm200605a","article-title":"Important role of oxidative stress biomarkers in Huntington\u2019s disease","volume":"54","author":"Tunez","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tiv.2024.105940_bb0415","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fnmol.2018.00467","article-title":"Dopamine autoxidation is controlled by acidic pH","volume":"11","author":"Umek","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tiv.2024.105940_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00702-023-02709-3","article-title":"The specific NQO2 inhibitor, S29434, only marginally improves the survival of dopamine neurons in MPTP-intoxicated mice","volume":"131","author":"Vallucci","year":"2024","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.tiv.2024.105940_bb0425","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00702-019-02133-6","article-title":"6-Hydroxydopamine: a far from simple neurotoxin","volume":"127","author":"Vare\u0161lija","year":"2020","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.tiv.2024.105940_bb0430","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11064-011-0619-7","article-title":"Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson\u2019s disease","volume":"37","author":"Venkateshappa","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tiv.2024.105940_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.273","article-title":"Contribution of Sigma-1 receptor to cytoprotective effect of afobazole","volume":"4","author":"Voronin","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.tiv.2024.105940_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313061","article-title":"Neuroprotective properties of Quinone reductase 2 inhibitor M-11, a 2-Mercaptobenzimidazole derivative","volume":"22","author":"Voronin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2024.105940_bb0445","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.freeradbiomed.2005.10.063","article-title":"Nuclear factor Nrf2 and antioxidant response element regulate NRH:quinone oxidoreductase 2 (NQO2) gene expression and antioxidant induction","volume":"40","author":"Wang","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2024.105940_bb0450","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/gerona\/63.2.127","article-title":"Association of NRH:quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson\u2019s disease","volume":"63","author":"Wang","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.tiv.2024.105940_bb0455","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chembiol.2009.12.013","article-title":"Activation of the NRF2 signaling pathway by copper-mediated redox cycling of Para- and ortho-hydroquinones","volume":"17","author":"Wang","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tiv.2024.105940_bb0460","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.toxlet.2017.10.021","article-title":"Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer\u2019s disease","volume":"282","author":"Wang","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tiv.2024.105940_bb0465","doi-asserted-by":"crossref","first-page":"11738","DOI":"10.18632\/aging.202868","article-title":"Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson's disease models","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.tiv.2024.105940_bb0470","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1124\/jpet.107.127597","article-title":"Mitochondrial complex I inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells","volume":"323","author":"Watabe","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2024.105940_bb0475","series-title":"Launch of WHO\u2019s Parkinson Disease Technical Brief","author":"WHO","year":"2022"},{"key":"10.1016\/j.tiv.2024.105940_bb0480","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/abbi.1997.0344","article-title":"Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase","volume":"347","author":"Wu","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tiv.2024.105940_bb0485","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tiv.2024.105940_bb0490","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jpi.12162","article-title":"Melatonin: a well-documented antioxidant with conditional pro-oxidant actions","volume":"57","author":"Zhang","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.tiv.2024.105940_bb0495","first-page":"4587","article-title":"Effects of resveratrol on learning and memory in rats with vascular dementia","volume":"20","author":"Zhang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.tiv.2024.105940_bb0500","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/acschemneuro.8b00450","article-title":"Implications of successful symptomatic treatment in Parkinson\u2019s disease for therapeutic strategies of Alzheimer\u2019s disease","volume":"10","author":"Zhao","year":"2019","journal-title":"ACS Chem. Neurosci."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723332400170X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723332400170X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T20:07:41Z","timestamp":1731096461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088723332400170X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":100,"alternative-id":["S088723332400170X"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2024.105940","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro modelling of Parkinson's disease using 6-OHDA is associated with increased NQO2 activity","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2024.105940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105940"}}